Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H25N5O8S |
| Molecular Weight | 471.485 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO\N=C(/C(=O)N[C@H]1[C@H](C)N(OCC(=O)OCC(=O)OC(C)(C)C)C1=O)C2=CSC(N)=N2
InChI
InChIKey=QPWVHJDIDXILDG-SSUKDTCJSA-N
InChI=1S/C18H25N5O8S/c1-9-13(21-15(26)14(22-28-5)10-8-32-17(19)20-10)16(27)23(9)30-7-11(24)29-6-12(25)31-18(2,3)4/h8-9,13H,6-7H2,1-5H3,(H2,19,20)(H,21,26)/b22-14-/t9-,13-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/3754552
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3754552
Gloximonam (SQ-82531) is a beta-lactam antibiotic. This is a class of antibiotics that contains a beta-lactam ring in their molecular structure, such as penicillin derivatives. Gloximonam is orally absorbed and has shown anti-bacterial activity against different bacteria of the Enterobacteriaceae and Haemophilus influenzae families. Gloximonam is not effective against staphylococci and strict anaerobes (like aztreonam) and (unlike aztreonam) against Pseudomonas aeruginosa.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C260
Created by
admin on Mon Mar 31 17:49:27 GMT 2025 , Edited by admin on Mon Mar 31 17:49:27 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5836
Created by
admin on Mon Mar 31 17:49:27 GMT 2025 , Edited by admin on Mon Mar 31 17:49:27 GMT 2025
|
PRIMARY | |||
|
C65806
Created by
admin on Mon Mar 31 17:49:27 GMT 2025 , Edited by admin on Mon Mar 31 17:49:27 GMT 2025
|
PRIMARY | |||
|
9J68LNZ9ZL
Created by
admin on Mon Mar 31 17:49:27 GMT 2025 , Edited by admin on Mon Mar 31 17:49:27 GMT 2025
|
PRIMARY | |||
|
SUB07935MIG
Created by
admin on Mon Mar 31 17:49:27 GMT 2025 , Edited by admin on Mon Mar 31 17:49:27 GMT 2025
|
PRIMARY | |||
|
100000084206
Created by
admin on Mon Mar 31 17:49:27 GMT 2025 , Edited by admin on Mon Mar 31 17:49:27 GMT 2025
|
PRIMARY | |||
|
5492073
Created by
admin on Mon Mar 31 17:49:27 GMT 2025 , Edited by admin on Mon Mar 31 17:49:27 GMT 2025
|
PRIMARY | |||
|
DTXSID001024756
Created by
admin on Mon Mar 31 17:49:27 GMT 2025 , Edited by admin on Mon Mar 31 17:49:27 GMT 2025
|
PRIMARY | |||
|
90850-05-8
Created by
admin on Mon Mar 31 17:49:27 GMT 2025 , Edited by admin on Mon Mar 31 17:49:27 GMT 2025
|
PRIMARY | |||
|
X-5
Created by
admin on Mon Mar 31 17:49:27 GMT 2025 , Edited by admin on Mon Mar 31 17:49:27 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107413
Created by
admin on Mon Mar 31 17:49:27 GMT 2025 , Edited by admin on Mon Mar 31 17:49:27 GMT 2025
|
PRIMARY |
ACTIVE MOIETY